Observational Study of COVID-19 Treatment Efficacy
NCT04369989 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2022-09-29
Summary
To compare various treatments provided to positive COVID-19 patients at locations across the OSF Ministry. Provide the opportunity to compare the effectiveness of various treatments and treatment timelines provided to specific cohorts of patients that have the potential to impact future treatment plans for COVID-19 patients and/or future research hypotheses.
Conditions
Interventions
- OTHER
-
No intervention
No intervention
Sponsors & Collaborators
-
OSF Healthcare System
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-04-14
- Primary Completion
- 2021-04-14
- Completion
- 2021-04-14
Countries
- United States
Study Locations
More Related Trials
-
Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19
NCT04532931 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)
NCT04575597 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 Disease
NCT04382924 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.
NCT05785390 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001)
NCT04575584 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Assessing Hydroxychloroquine in Patients With SARS-CoV-2 (COVID-19)
NCT04363866 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy of Faviprevir in COVID-19 Treatment
NCT04351295 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study to AntagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19
NCT04634799 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19
NCT04343742 ·Status: UNKNOWN
-
Effect of Pentoxifylline on Prognosis of Coronavirus Disease 2019 (COVID- 19) Infection
NCT04739345 ·Status: COMPLETED ·Phase: NA
-
The Real-world Clinical Study of Azvudine Tablets in the Treatment of COVID-19
NCT06349655 ·Status: COMPLETED
-
Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic
NCT04668469 ·Status: COMPLETED ·Phase: NA
-
The Efficacy of Azvudine and Paxlovid in High-risk Patients With COVID-19: A Prospective Randomized Controlled Trial
NCT05642910 ·Status: UNKNOWN ·Phase: NA
-
Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care
NCT04334967 ·Status: SUSPENDED ·Phase: PHASE4
-
A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia
NCT04261270 ·Status: UNKNOWN ·Phase: PHASE3
-
Real World COVID-19 Antiviral Effectiveness Research
NCT05638919 ·Status: UNKNOWN
-
CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients
NCT04734873 ·Status: TERMINATED ·Phase: PHASE3
-
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
NCT05047601 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Etoposide in Patients With COVID-19 Infection
NCT04356690 ·Status: TERMINATED ·Phase: PHASE2
-
Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19
NCT04331899 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Combination Therapies to Treat COVID-19 Infection
NCT04459702 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection
NCT04637828 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Obeldesivir in Participants With COVID-19 Who Have a High Risk of Developing Serious or Severe Illness
NCT05603143 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia
NCT04613271 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Obeldesivir in Nonhospitalized Participants With COVID-19
NCT05715528 ·Status: COMPLETED ·Phase: PHASE3